Please login to the form below

Not currently logged in
Email:
Password:

Targovax appoints Oystein Soug as CEO

CFO takes on top role as Gunnar Gårdemyr steps down

Targovax Oystein SougNorwegian immuno-oncology specialist Targovax has appointed Oystein Soug as its new chief executive officer following the resignation of Gunnar Gåardemyr.

Formerly chief financial officer, Soug joined Targovax in 2015 bringing over 20 years of financial management experience to the role.

He has previously served as chief financial officer for Algeta, a Norwegian oncology biotech that was bought by Bayer in 2014, and spent six years at Orkla, a Norwegian consumer goods company.

Jónas Einarsson, chairman of Targovax's board of directors, said: “We are delighted to announce the appointment of Oystein as the new chief executive officer of Targovax.

“He has played a key role as chief financial officer over the past year - successfully guiding us on the path to becoming a publicly-listed company, securing funding for further development of the company's ongoing and planned trials.

“We are confident in his ability to lead the company as we approach important milestones in 2017 and 2018 in our innovative clinical pipeline designed to help the patient's own immune system fight cancer.”

16th November 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...